X -LINKED RETINITIS PIGMENTOSA (XLRP) IS A SEVERE
form of RP with an early-onset night blindness, progressive visual field constriction, and gradual central vision loss that leads to legal blindness by the third and fourth decades. Mutations in RPGR (RP3, Xp21.1) are responsible for up to 70% of XLRP 1 and also cause X-linked cone-rod dystrophy (CORDX1) 2 and atrophic macular degeneration. 3 Coats' disease is a sporadic form of exudative retinal telangiectasia. It is usually unilateral, affects the young male patients, and manifests in the first decade of life with intra-and subretinal exudates and dilated tortuous retinal vessels. Retinal telangiectasis that resembles Coats' disease is an uncommon (1.2% to 4.9%) complication of RP and differs from Coats' disease with regard to age (relatively older age), gender (no sex preference), bilateral eye involvement (more often bilateral), progression (more severe prognosis), and retinal location (mainly inferior quadrants and multifocal). 4 Fifty-five percent of Coats'-like RP cases have been found to be associated with CRB1 mutations. 5 The proband was first seen at age 8 years, with a chief complaint of longstanding night blindness and a history of mild amblyopia in the right eye. Family history revealed RP in his brother, two maternal uncles, and one maternal cousin, which is consistent with XL inheritance. He had mild myopia (-5.25 ϩ 1.75 ϫ 115 oculus dexter; -2.50 ϩ 1.25 ϫ 160 oculus sinister), corrected visual acuities of 20/60 oculus dexter and 20/50 oculus sinister, and bilateral markedly constricted confrontation visual fields. Fundus examination revealed markedly attenuated retinal vessels and extensive midperipheral pigment epithelial changes, with rare areas of intraretinal pigment. In the inferior midperiphery of the left eye, there was a small area of retinovascular leakage with mild exudates and edema. Because this involved an already atrophic area, no treatment was undertaken, and a 6-month follow-up period was recommended. The patient returned 2.5 years later (age, 10.5 years) with markedly decreased vision (oculus dexter: hand motions; oculus sinister: 20/200), bilateral intra-and subretinal exudates, hemorrhage, and macular edema (oculus dexter Ͼ oculus sinister). Multiple sessions of modified fluorescein-potentiated argon laser photocoagulation (FPAL) 6 were applied to vascular leakage areas over a 1-year period. During a 2-year period, the lesions regressed; exudates resolved, and retina reattached ( Figures  1 and 2 ). At his most recent visit (age, 16 years), his vision and retinal status were stable in both eyes.
Clinical findings of other family members (two affected male patients and three obligate carrier female patients) were consistent with typical X-linked-recessive RP with posterior subcapsular cataract complication. The proband was the only family member who had Coats'-like RP. Informed consent was obtained before participation in the study in accordance with a University of Pittsburgh institutional review board-approved protocol. The leukocyte genomic DNA samples were obtained and screened for RPGR mutations with direct polymerase chain reaction sequencing of the coding exons and flanking intronic regions. A novel nonsense RPGR exon ORF15 mutation (912GϾT) was found to segregate with RP in this family (Figure 3) .
Our findings provide several new observations for which we could find no reference from a computerized MEDLINE search: (1) association of XLRP with Coats'-like vasculopathy, (2) a novel RPGR mutation that confirmed XLRP diagnosis, and (3) use of FPAL as an effective therapy for Coats'-like RP. This report expands the clinical heteroge- Consistent with previous reports, Coats' response was not observed in all affected family members, which suggests the involvement of genetic and/or environmental factors that are independent of RP-causing mutation. One study reported the association of germline or somatic Norrie disease gene (NDP, Xp11.4) mutations with Coats' disease 7 ; however, the NDP sequencing did not reveal any germline variants in our family.
Because of their RP-related visual impairment, the patients may not notice the effects of Coats' response at early stages.
It is important to offer periodic retinal examinations to at-risk patients because early recognition and treatment of the problem may lead to a better prognosis. Treatment options include cryotherapy, scleral buckling with subretinal fluid drainage, and traditional photocoagulation. The FPAL appears to be an efficient and the least invasive treatment option for the management of this complication.
